Ezio Bonifacio
Overview
Explore the profile of Ezio Bonifacio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
7917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aljani B, Lindner A, Weigelt M, Zhao M, Sharma V, Bonifacio E, et al.
Islets
. 2024 Aug;
16(1):2392343.
PMID: 39154325
Replacement of beta cells through transplantation is a potential therapeutic approach for individuals with pancreas removal or poorly controllable type 1 diabetes. However, stress and death of beta cells pose...
12.
Friedl N, Sporreiter M, Winkler C, Heublein A, Haupt F, Ziegler A, et al.
JAMA
. 2024 Jul;
332(6):501-502.
PMID: 39008327
No abstract available.
13.
Jonsdottir B, Clasen J, Vehik K, Lernmark A, Lundgren M, Bonifacio E, et al.
J Clin Endocrinol Metab
. 2024 Jul;
110(2):498-510.
PMID: 38996042
Context: Autoantibodies to thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) define preclinical autoimmune thyroid disease (AITD), which can progress to either clinical hypothyroidism or hyperthyroidism. Objective: We determined the age at...
14.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetes Care
. 2024 Jun;
47(8):1276-1298.
PMID: 38912694
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease...
15.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia
. 2024 Jun;
67(9):1731-1759.
PMID: 38910151
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease...
16.
Zeller I, Weiss A, Arnolds S, Schutte-Borkovec K, Arabi S, von dem Berge T, et al.
Infection
. 2024 Jun;
52(6):2465-2473.
PMID: 38874748
Objectives: To determine the impact of the COVID-19 pandemic on the incidence rates of infection and islet autoimmunity in children at risk for type 1 diabetes. Methods: 1050 children aged...
17.
Singh T, Weiss A, Vehik K, Krischer J, Rewers M, Toppari J, et al.
Diabetologia
. 2024 May;
67(8):1582-1587.
PMID: 38819466
Aims/hypothesis: Delivery by Caesarean section continues to rise globally and has been associated with the risk of developing type 1 diabetes and the rate of progression from pre-symptomatic stage 1...
18.
Bonifacio E, Winkler C, Achenbach P, Ziegler A
Lancet Diabetes Endocrinol
. 2024 May;
12(6):376-378.
PMID: 38723647
No abstract available.
19.
Achenbach P, Berner R, Bonifacio E, Bramswig S, Braig S, Dunstheimer D, et al.
Gesundheitswesen
. 2024 May;
87(1):27-37.
PMID: 38710228
This position paper is based on the authors' many years of clinical experience and basic science research on the diagnosis and treatment of children and adolescents with a presymptomatic early...
20.
Hendriks A, Marcovecchio M, Besser R, Bonifacio E, Casteels K, Elding Larsson H, et al.
Diabetes Metab Res Rev
. 2024 Feb;
40(2):e3777.
PMID: 38375753
Background/aim: Type 1 diabetes is an autoimmune disease that involves the development of autoantibodies against pancreatic islet beta-cell antigens, preceding clinical diagnosis by a period of preclinical disease activity. As...